20241212_Lung-fibrosis_Khan_colour2 (IMAGE) European Molecular Biology Laboratory Caption A new study has explored the potential of Dextromethorphan, an FDA-approved drug, in the treatment of lung fibrosis. Lung fibrosis occurs after accumulation of scar tissue in the lung (left image shows a mice lung with scarring tissue) which was reduced after treatment with Dextromethorphan (right image). Credit Muzamil Khan and Creative Team /EMBL Usage Restrictions Credit must be given to the creator. Only noncommercial uses of the work are permitted. Adaptations must be shared under the same terms. License CC BY-NC-SA Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.